Related Experiment Video
Updated: Jun 23, 2026
07:49
A Pacing-Controlled Procedure for the Assessment of Heart Rate-Dependent Diastolic Functions in Murine Heart Failure Models
Published on: July 21, 2023
Natriuretic peptide guided heart failure management.
Asim A Mohammed1, James L Januzzi
1Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, MA 02114, USA.
Current Clinical Pharmacology
|May 16, 2009
Summary
Natriuretic peptide testing, including BNP and NT-proBNP, improves acute heart failure management. This testing also shows promise for guiding therapy in stable chronic heart failure patients.
Area of Science:
- Cardiology
- Biomarker Research
- Heart Failure Management
Background:
- Natriuretic peptide testing (BNP or NT-proBNP) has significantly impacted acute heart failure patient care.
- Recent research indicates its potential utility in managing stable chronic heart failure in outpatient settings.
Purpose of the Study:
- To review the current understanding of using natriuretic peptide testing to guide heart failure therapy.
- To explore present and future directions for natriuretic peptide-guided heart failure treatment.
Main Methods:
- Literature review of studies on natriuretic peptide testing in heart failure management.
- Analysis of current clinical applications and emerging research.
Main Results:
- Natriuretic peptide testing aids in early recognition, prognostication, and treatment of acute heart failure.
- Evidence suggests natriuretic peptide testing can guide therapy for stable chronic heart failure patients.
Conclusions:
- Natriuretic peptide testing is a valuable tool in both acute and chronic heart failure management.
- Further research and clinical integration are expected to expand its role in guiding heart failure therapy.
Related Concept Videos
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:30Heart Failure VII: Nursing Interventions
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:28Mitral Regurgitation IV: Nursing Management
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...